{"id":"NCT02487446","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety Study of QVA149 in COPD Patients","officialTitle":"A Multi-center, Randomized, Double-blind, Double-dummy, Active Controlled, 2-period Cross-over Study to Assess the Efficacy, Safety and Tolerability of Indacaterol Maleate/Glycopyrronium Bromide Compared to Umeclidinium Bromide/Vilanterol in COPD Patients With Moderate to Severe Airflow Limitation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-07-28","primaryCompletion":"2016-09-12","completion":"2016-09-12","firstPosted":"2015-07-01","resultsPosted":"2017-12-26","lastUpdate":"2017-12-26"},"enrollment":357,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"QVA149","otherNames":["Indecaterol maleate/glycopyrronium bromide"]},{"type":"DRUG","name":"Umeclidinium/vilanterol","otherNames":["ELLIPTAÂ®"]},{"type":"DRUG","name":"Placebo (umeclidinium/vilanterol)","otherNames":[]},{"type":"DRUG","name":"Placebo (QVA149)","otherNames":[]}],"arms":[{"label":"First QVA149, then Umeclidinium/vilanterol","type":"EXPERIMENTAL"},{"label":"First Umeclidinium/vilanterol, then QVA149","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to demonstrate that the efficacy of the combination product QVA149 is similar to the efficacy of the combination product umeclidinium/vilanterol on a pre-specified endpoint of FEV1 AUC0-24h while maintaining an acceptable safety profile.","primaryOutcome":{"measure":"Change From Baseline in Forced Expiratory Volume (FEV1) Area Under the Curve (AUC) 0-24h","timeFrame":"baseline, 0 to 24 hours post-dose at week 12","effectByArm":[{"arm":"QVA149","deltaMin":0.2321,"sd":0.01133},{"arm":"Umeclidinium/Vilanterol","deltaMin":0.2436,"sd":0.0113}],"pValues":[{"comp":"OG000 vs OG001","p":"0.139"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":9},"locations":{"siteCount":58,"countries":["United States"]},"refs":{"pmids":["28993871"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":13,"n":341},"commonTop":["Chronic obstructive pulmonary disease","Nasopharyngitis","Upper respiratory tract infection","Bronchitis","Dyspnoea"]}}